Sofosbuvir and Velpatasvir

Sofosbuvir and Velpatasvir on the U.S. market: products, makers and brands

How Sofosbuvir and Velpatasvir appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

2 companies list 5 Sofosbuvir and Velpatasvir product records with the FDA, mostly as tablet, other oral form; the earliest marketing or approval year on record is 2016. Brand names on the directory include Epclusa; the rest are generics.

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Sofosbuvir and Velpatasvir is used (Medicaid data)

A general measure of how commonly Sofosbuvir and Velpatasvir is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Sofosbuvir and Velpatasvir is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

How commonly is Sofosbuvir and Velpatasvir prescribed? Of the 1,601 medications we measure, Sofosbuvir and Velpatasvir ranks #641 by Medicaid prescriptions — more than 60% of them.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Sofosbuvir and Velpatasvir, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 3 of 5 listed Sofosbuvir and Velpatasvir NDCs with Medicaid activity.

Compare Sofosbuvir and Velpatasvir products

A representative set of FDA-listed product records for Sofosbuvir and Velpatasvir — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 5 of 5 products — FDA National Drug Code Directory. See every product, package size and price: browse all 5 Sofosbuvir and Velpatasvir NDCs →

💵 What Sofosbuvir and Velpatasvir costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Sofosbuvir and Velpatasvir brand names

Sofosbuvir and Velpatasvir is sold under one brand name in the FDA directory — Epclusa. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Who makes Sofosbuvir and Velpatasvir: manufacturers and labelers

2 companies list Sofosbuvir and Velpatasvir products with the FDA. By number of product records, the largest are Gilead Sciences, Inc., Asegua Therapeutics LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Medications related to Sofosbuvir and Velpatasvir